Cargando…
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease‐Activated Receptor Pathway
BACKGROUND: An enhanced renin‐angiotensin system causes hypertensive renal damage. Factor Xa not only functions in the coagulation cascade but also activates intracellular signaling through protease‐activated receptors (PAR). We investigated the effects of rivaroxaban, a factor Xa inhibitor, on hype...
Autores principales: | Ichikawa, Hiroaki, Shimada, Michiko, Narita, Masato, Narita, Ikuyo, Kimura, Yoshihiro, Tanaka, Makoto, Osanai, Tomohiro, Okumura, Ken, Tomita, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507187/ https://www.ncbi.nlm.nih.gov/pubmed/30957622 http://dx.doi.org/10.1161/JAHA.119.012195 |
Ejemplares similares
-
Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm
por: Kinjo, Takahiko, et al.
Publicado: (2015) -
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
por: Shimada, Michiko, et al.
Publicado: (2017) -
Successful Resuscitation of a Patient with Life-Threatening Metabolic Acidosis by Hemodialysis: A Case of Ethylene Glycol Intoxication
por: Narita, Ikuyo, et al.
Publicado: (2017) -
IQGAP1 activates PLC‐δ1 by direct binding and moving along microtubule with DLC‐1 to cell surface
por: Tanaka, Makoto, et al.
Publicado: (2019) -
Peritoneal Dialysis with Marked Pneumoperitoneum
por: Nakamura, Norio, et al.
Publicado: (2020)